Los Angeles, CA (PRWEB) January 08, 2013
The Food and Drug Administration issued warning letters (found here: goo.gl/WC3fX) to more than 350 medical practices that bought unapproved and possibly fake Botox from a Canadian supplier. That supplier, Canada Drugs, also trades under the names A+ Health Supplies, Quality Specialty Products, Clinical Care, Bridgewater Medical and QP Medical. The FDA warned in its letter that this unapproved, fake Botox fails to meet U.S. standards for storage, handling and transporting, and the supplies could prove counterfeit or contaminated.
Some medical offices attempt to cut costs by ordering cheaper drugs from Canadian and foreign suppliers, but this practice violates U.S. law. Reached for comment, Simon Ourian, M.D., Medical Director of Epione Beverly Hills, a leading provider of Botox
No comments:
Post a Comment